Company Quick10K Filing
Tauriga Sciences
10-Q 2020-12-31 Filed 2021-02-22
10-Q 2020-09-30 Filed 2020-11-16
10-Q 2020-06-30 Filed 2020-08-14
10-K 2020-03-31 Filed 2020-06-29
S-1 2020-03-05 Public Filing
10-Q 2019-12-31 Filed 2020-02-13
10-Q 2019-09-30 Filed 2019-11-12
10-Q 2019-06-30 Filed 2019-08-13
10-K 2019-03-31 Filed 2019-06-27
10-Q 2018-12-31 Filed 2019-01-29
10-Q 2018-09-30 Filed 2018-10-31
10-Q 2018-06-30 Filed 2018-07-31
10-K 2018-03-31 Filed 2018-06-27
10-Q 2017-12-31 Filed 2018-02-12
10-Q 2017-09-30 Filed 2017-11-13
10-Q 2017-06-30 Filed 2017-08-07
10-K 2017-03-31 Filed 2017-07-07
10-Q 2016-12-31 Filed 2017-01-31
10-Q 2016-09-30 Filed 2016-12-05
10-Q 2016-06-30 Filed 2016-11-09
10-K 2016-03-31 Filed 2016-10-14
10-Q 2015-12-31 Filed 2016-08-09
10-Q 2015-09-30 Filed 2016-07-12
10-Q 2015-06-30 Filed 2016-06-29
10-K 2015-03-31 Filed 2016-05-20
10-Q 2014-12-31 Filed 2015-02-17
10-Q 2014-09-30 Filed 2014-11-19
10-Q 2014-06-30 Filed 2014-08-19
10-K 2014-03-31 Filed 2014-07-15
10-Q 2013-12-31 Filed 2014-02-19
10-Q 2013-09-30 Filed 2013-11-19
10-Q 2013-06-30 Filed 2013-08-19
10-K 2013-03-31 Filed 2013-07-12
10-Q 2012-12-31 Filed 2013-02-19
10-Q 2012-09-30 Filed 2012-11-16
10-Q 2012-06-30 Filed 2012-08-14
10-K 2012-03-31 Filed 2012-07-16
10-Q 2011-12-31 Filed 2012-02-21
10-Q 2011-09-30 Filed 2011-11-21
10-Q 2011-06-30 Filed 2011-08-22
10-K 2011-03-31 Filed 2011-07-14
10-Q 2010-12-31 Filed 2011-02-22
10-Q 2010-09-30 Filed 2010-11-22
10-Q 2010-06-30 Filed 2010-08-23
10-K 2010-03-31 Filed 2010-07-14
10-Q 2009-12-31 Filed 2010-02-22
8-K 2020-11-18
8-K 2020-09-24
8-K 2020-07-15
8-K 2020-06-16
8-K 2020-06-04
8-K 2020-04-17
8-K 2020-03-17
8-K 2020-01-21
8-K 2019-12-16
8-K 2019-11-25
8-K 2019-09-13
8-K 2019-09-10
8-K 2019-07-18
8-K 2019-06-28
8-K 2019-05-27
8-K 2019-04-30
8-K 2019-03-14
8-K 2019-01-14
8-K 2018-07-06
8-K 2018-04-09
8-K 2018-02-14
8-K 2017-12-27

Tauriga Sciences Financials

TAUG Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
024 Pharma (EEIG)
11 Good Energy (ELVN)
1347 Capital Corp (TFSC)
Ameren Illinois Co (AILNP)
1PM Industries (OPMZ)
1st Century Bancshares (FCTY)
1st Financial Services Corp (FFIS)
1st United Bancorp (FUBC)
2-Track Global (TTG)
ENTERGY ARKANSAS, LLC (EAI)
21st Century Oncology Holdings (RTSX)
ALTIMAR ACQUISITION CORP. (ATAC-WT)
AppHarvest, Inc. (APPHW)
24Holdings (TWFH)
AMERICAN CRYOSTEM Corp (CRYO)
BorrowMoney.com, Inc. (BWMY)
CAT9 Group Inc. (CATN)
30DC (TDCH)
CBL & ASSOCIATES PROPERTIES INC (CBLEQ)
ALABAMA POWER CO (APRCP)

Balance Sheet ($'000)2011-09-302011-12-312012-03-312012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash21706207114391202588137144053162098574006000790715123513103861530
Accounts Receivable11311112872
Inventory26891870017000011139125
PP&E7183650505354555566666767675656565656112232121213131313
Assets96556682721992755961,6653,1442,9642,3712,32135922293141070324109351,097689982763574961827659
Accounts Payable19822520929127728027230229528126927427231530431430729127325727927526213530524473352739
Long-Term Debt37418225418215915928021
Liabilities8431,4967387231,1831,5951,5841,3872,8851,1831,1551,5701,6791,5433,1362,0892,3052,4662,9612,6832,5402,4112,191552394419334486457308432
Stockholders' Equity-834-841-70-451-985-1,320-9882792591,7811,216752-1,320-1,321-3,043-2,075-2,295-2,459-2,961-2,651-2,537-2,302-2,15654529756543190503519228
Income Statement ($'000)2011-09-302011-12-312012-03-312012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue1129564100000000010005744114
Cost of Revenue393080000000001000372961
Gross Profit82027330000000000000020158
R&D0081942181440-1400106222530011340
SG&A5613073,7673,7672,8952,0441,2551,1621,6811,3351,5127173183084922151,04076731131045474627520340222296201369759427
Tax00000000000000000000
Net Income917-325-4,595-3,593-2,939-2,451-297-1,599-4,492-1,576-1,796-1,385-308-251-1,882813-1,249-903-545-658-165-624-6541,570-373167-266-378-621-658-630
Cash Flow ($'000)2011-09-302011-12-312012-03-312012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating-224-1,499-733-128-722-338-445-414-509-563-530-242-127-201-263-284-101-157-259-2401,1592,310-113-207205-475-180
Cash Investing-13-21-840-49-131-16-96-451-29-10-100201-190-10-20-481-313111234-500-200
Cash Financing4081,9901,9972507974673921,620442262441843170282291103156340161371125-50671125195